Lenalidomide Maintenance for Diffuse Large B‐cell Lymphoma Patients Responding to R‐CHOP: Quality of Life, Dosing, and Safety Results from the Randomised Controlled REMARC Study Catherine Thieblemont , Susannah Howlett , Rene-Olivier Casasnovas , Nicolas Mounier , Aurore Perrot , Franck Morschhauser , Christophe Fruchart , Nicolas Daguindau , Koen van Eygen , Lucie Oberic , Reda Bouabdallah , Gian Matteo Pica , Emmanuelle Nicolas-Virezelier , Julie Abraham , Olivier Fitoussi , Sylvia Snauwaert , Jean-Claude Eisenmann , Pauline Lionne-Huyghe , Dominique Bron , Sabine Tricot , Dries Deeren , Hugo Gonzalez , Regis Costello , Katell Le Du , Maria Gomes da Silva , Sebastian Grosicki , Judith Trotman , John Catalano , Dolores Caballero , Richard Greil , Amos M. Cohen , Philippe Gaulard , Louise Roulin , Kenichi Takeshita , Marie-Laure Casadebaig , Herve Tilly , Bertrand Coiffier British Journal of Haematology（2019）
Key words
non-Hodgkin lymphoma, quality of life, therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
